Mechanism of Action and Value of N-Acetylcysteine in the Treatment of Early and Late Acetaminophen Poisoning: A Critical Review

References

• Gunnell D., Hawton K., Murray V. Use of paracetamol for suicide and non-fatal poisoning in the UK and France: Are restrictions on availability justified. J Epidemiol Community Health 1997; 51: 175–179
   PubMed Web of Science ®Google Scholar
• Hawton K., Fagg J. Trends in deliberate self poisoning and self injury in Oxford, 1976–90. BMJ 1992; 304: 1409–1411
   PubMed Web of Science ®Google Scholar
• Annual Report of the Registrar General of Births. Deaths and Marriages for Scotland. HMSO. 1995
   Google Scholar
• Spooner J. B., Harvey JG. Paracetamol overdosage—Facts, not misconceptions. Pharm J 1993; 250: 706–707
   Google Scholar
• Neeleman J., Wessely S. Drugs taken in fatal and nonfatal self-poisoning: A study in south London. Acta Psychiatr Scand 1997; 95: 283–287
   PubMed Web of Science ®Google Scholar
• Litovitz T. L., Smilkstein M., Felberg L., Klein-Schwartz W., Berlin R., Morgan JL. 1996 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Enterg Med 1997; 15: 447–500
   Web of Science ®Google Scholar
• Prescott L. F., Donovan J. W., Jarvie D. R., Proudfoot AT. The disposition and kinetics of intravenousN-acetylcysteine in patients with paracetamol overdosage. Eur J Clin Pharmacol 1989; 37: 501–506
   PubMed Web of Science ®Google Scholar
• Hultberg B., Andersson A., Masson P., Larson M., Tunek A. Plasma homocysteine and thiol compound fractions after oral administration ofN-acetylcysteine. Scand J Clin Lab Invest 1994; 54: 417–422
   PubMed Web of Science ®Google Scholar
• Borgstrom L., Kagedal B., Paulson O. Pharmacokinetics ofN-acetylcysteine in man. Eur J Clin Pharmacol 1986; 31: 217–222
   PubMed Web of Science ®Google Scholar
• Sjodin K., Nilsson E., Hallberg A., Tunek A. Metabolism ofN-acetyl-L-cysteine. Some structural requirements for the deacetylation and consequences for the oral bioavailability. Biochem Pharmacol 1989; 38: 3981–3985
   PubMed Web of Science ®Google Scholar
• Cotgreave I. A., Berggren M., Jones T. W., Dawson J., Moldeus P. Gastrointestinal metabolism ofN-acetylcysteine in the rat, including an assay for sulfite in biological systems. Biopharm Drug Dispos 1987; 8: 377–386
   PubMed Web of Science ®Google Scholar
• Bonanomi L., Gazzaniga A. Toxicological, pharmacokinetic and metabolic studies on acetylcysteine. Eur J Respir Dis Suppl 1980; 111: 45–51
   PubMedGoogle Scholar
• Sheffner A. L., Medler E. M., Bailey K. R., Gallo D. G., Mueller A. J., Sarett HP. Metabolic studies with acetylcysteine. Biochem Pharmacol 1966; 15: 1523–1535
   PubMed Web of Science ®Google Scholar
• Lauterburg B. H., Corcoran G. B., Mitchell JR. Mechanism of action ofN-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats. in vivo. J Oin Invest 1983; 71: 980–991
   PubMed Web of Science ®Google Scholar
• Jones A. L., Jarvie D. R., Simpson D., Hayes P. C., Prescott LF. Pharmacokinetics ofN-acetylcysteine are altered in patients with chronic liver disease. Aliment Pharmacol Ther 1997; 11: 787–791
   PubMed Web of Science ®Google Scholar
• De Vries J. Hepatotoxic metabolic activation of paracetamol and its derivatives phenacetin and benoril-ate: Oxygenation or electron transfer. Biochem Pharmacol 1981; 30: 399–402
   PubMed Web of Science ®Google Scholar
• Gemborys M. W., Mudge G. H., Gribble GW. Mechanism of decomposition of jV-hydroxyacetaminophen, a postulated toxic metabolite of acetaminophen. J Med Chem 1980; 23: 304–308
   PubMed Web of Science ®Google Scholar
• Jollow D. J., Mitchell J. R., Potter W. Z., Davis D. C., Gilette J. R., Brodie BB. Acetaminophen-induced hepatic necrosis. JJ. Role of covalent binding. in vitro. J Pharmacol Exp Ther 1973; 187: 195–202
   PubMed Web of Science ®Google Scholar
• Mitchell J. R., Jollow D. J., Potter W. Z., Davis D. C., Gillette J. R., Brodie BB. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther 1973; 187: 185–194
   PubMed Web of Science ®Google Scholar
• Potter W. Z., Davis D. C., Mitchell J. R., Jollow D. J., Gillette J. R., Brodie BB. Acetaminophen-induced hepatic necrosis. HI. Cytochrome P-450-mediated covalent binding. in vitro. J Pharmacol Exp Ther 1973; 187: 203–210
   PubMed Web of Science ®Google Scholar
• Prescott L. F., Illingworth R. N., Critchley J. A., Stewart M. J., Adam R. D., Proudfoot AT. IntravenousN-acetylcysteine: The treatment of choice for paracetamol poisoning. Br Med J 1979; 2: 1097–1100
   PubMed Web of Science ®Google Scholar
• Mitchell J. R., Jollow D. J., Gillette J. R., Brodie BB. Drug metabolism as a cause of drug toxicity. Drug Metab Dispos 1973; 1: 418–423
   PubMed Web of Science ®Google Scholar
• Mitchell J. R., Thorgeirsson SS, Potter W. Z., Jollow D. J., Keiser H. Acetaminophen-induced hepatic injury: Protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther 1974; 16: 676–684
   PubMed Web of Science ®Google Scholar
• Mitchell J. R., Potter WZ. Drug metabolism in the production of liver injury. Med Clin North Am 1975; 59: 877–885
   PubMed Web of Science ®Google Scholar
• Mitchell J. R., Jollow D. J., Potter W. Z., Gillette J. R., Brodie BB. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther 1973; 187: 211–217
   PubMed Web of Science ®Google Scholar
• Smilkstein M. J., Knapp G. L., Kulig K. W., Rumack BH. Efficacy of oralN-acetylcysteine in the treatment of acetaminophen overdose: Analysis of the national multicenter study (1976–1985). N Engl J Med 1988; 319: 1557–1562
   PubMed Web of Science ®Google Scholar
• Bizovi K. E., Aks S. E., Paloucek F., Gross R., Keys N., Rivas J. Late increase in acetaminophen concentration after overdose of Tylenol Extended Relief. Ann Emerg Med 1996; 28: 549–551
   PubMed Web of Science ®Google Scholar
• Minton N. A., Henry J. A., Frankel RJ. Fatal paracetamol poisoning in an epileptic. Hum Toxicol 1988; 7: 33–34
   PubMedGoogle Scholar
• Janes J., Routledge PA. Recent developments in the management of paracetamol (acetaminophen) poisoning. Drug Saf 1992; 7: 170–177
   PubMed Web of Science ®Google Scholar
• Bray G. P., Harrison P. M., O'Grady J. G., Tredger J. M., Williams R. Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure. Hum Exp Toxicol 1992; 11: 265–270
   PubMed Web of Science ®Google Scholar
• Ferner R. Paracetamol poisoning—An update. Prescribers J 1993–33; 45–50
   Google Scholar
• Johnston S. C., Pelletier LL, Jr. Enhanced hepatotoxicity of acetaminophen in the alcoholic patients. Two case reports and a review of the literature. Medicine (Baltimore) 1997; 76: 185–191
   PubMed Web of Science ®Google Scholar
• Bray G. P., Mowat C., Muir D. F., Tredger J. M., Williams R. The effect of chronic alcohol intake on prognosis and outcome in paracetamol overdose. Hum Exp Toxicol 1991; 10: 435–438
   PubMed Web of Science ®Google Scholar
• McClain C. J., Kromhout J. P., Peterson F. J., Holtzman JL. Potentiation of acetaminophen hepatotoxicity by alcohol. JAMA 1980; 244: 251–253
   PubMed Web of Science ®Google Scholar
• Girre C., Hispard E., Palombo S., N'Huyen C., Dally S. Increased metabolism of acetaminophen in chronically alcoholic patients. Alcohol Clin Exp Res 1993; 17: 170–173
   PubMed Web of Science ®Google Scholar
• Prescott LF. Paracetamol (Acetaminophen). A Critical Bibliographic Review. Taylor & Francis, London 1996
   Google Scholar
• Dhawan A., Sorrell MF. Acetaminophen overdose: Need to consider intravenous preparation ofN-acetylcysteine in the United States. Am J Gastroenterol 1996; 91: 1476
   PubMed Web of Science ®Google Scholar
• Ekins B. R., Ford D. C., Thompson M. I., Bridges R. R., Rollins D. E., Jenkins RD. The effect of activated charcoal onN-acetylcysteine absorption in normal subjects. Am J Emerg Med 1987; 5: 483–487
   PubMed Web of Science ®Google Scholar
• Reed M. D., Marx CM. Ondansetron for treating nausea and vomiting in the poisoned patient. Ann Pharmaco-ther 1994; 28: 331–333
   PubMed Web of Science ®Google Scholar
• Clark R. F., Chen R., Wiliams S. R., Johnson C. L., Har-Chelroad F. The use of ondansetron in the treatment of nausea and vomiting associated with acetaminophen poisoning. J Toxicol Clin Toxicol 1996; 34: 163–167
   PubMed Web of Science ®Google Scholar
• Smilkstein M. J., Bronstein A. C., Linden C., Augenstein W. L., Kulig K. W., Rumack BH. Acetaminophen overdose: A 48-hour intravenousN-acetylcysteine treatment protocol. Ann Emerg Med 1991; 20: 1058–1063
   PubMed Web of Science ®Google Scholar
• Woo O. F., Anderson I. B., Kim S. Y., Mueller P., Keller K., Olson KR. Shorter duration ofN-acetylcysteine (NAC) for acute acetaminophen poisoning. J Toxicol Clin Toxicol 1995; 33: 508
   Google Scholar
• Blazka M. E., Wilmer J. L., Holladay S. D., Wilson R. E., Luster MI. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 1995; 133: 43–52
   PubMed Web of Science ®Google Scholar
• De la Mata M., Meager A., Rolando N. Tumor necrosis factor production in fulminant hepatic failure: Relation to aetiology and superimposed microbial infection. Gin Exp Immunol 1990; 82: 479–484
   PubMed Web of Science ®Google Scholar
• Meredith T. J., Prescott L. F., Vale JA. Why do patients still die from paracetamol poisoning. Br Med J (Clin Res Ed) 1986; 293: 345–346
   PubMed Web of Science ®Google Scholar
• Tredger J. M., O'Grady J. G., Williams R. Why do patients still die after paracetamol poisoning. Br Med J (Oin Res Ed) 1986; 293: 756–757
   PubMed Web of Science ®Google Scholar
• Harrison P. M., Keays R., Bray G. P., Alexander G. J., Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990; 335: 1572–1573
   PubMed Web of Science ®Google Scholar
• Keays R., Harrison P. M., Wendon J. A. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: A prospective controlled trial. BMJ 1991; 303: 1026–1029
   PubMed Web of Science ®Google Scholar
• Ellis A., Wendon J. Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: Pathophysiology and management. Semin Liver Dis 1996; 16: 379–388
   PubMed Web of Science ®Google Scholar
• Makin A. J., Wendon J., Williams R. A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987–1993). Gastroenterology 1995; 109: 1907–1916
   PubMed Web of Science ®Google Scholar
• Harrison P. M., Wendon J. A., Gimson A. E., Alexander G. J., Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991; 324: 1852–1857
   PubMed Web of Science ®Google Scholar
• Walsh T. S., Hopton P., Lee A. Oxygen consumption is independent of oxygen delivery following N-acetylcys-teine in fulminant hepatic failure. Intens Care Med 1996; 22: S436
   Google Scholar
• Walsh T. S., Hopton P., Lee A. The beneficial haemody-namic effects of N-acetylcysteine are shortlived in patients with fulminant hepatic failure. Intens Care Med 1996; 22: S313
   Google Scholar
• Bartlett R. H., Dechert RE. Oxygen kinetics: Pitfalls in clinical research. J Crit Care 1990; 5: 77–80
   Web of Science ®Google Scholar
• Archie JP, Jr. Mathematic coupling of data: A common source of error. Ann Surg 1981; 193: 296–303
   PubMed Web of Science ®Google Scholar
• Devlin J., Ellis A. E., McPeake J., Heaton N., Wendon J. A., Williams R. N-acetylcysteine improves indocya-nine green extraction and oxygen transport during hepatic dysfunction. Crit Care Med 1997; 25: 236–242
   PubMed Web of Science ®Google Scholar
• Lautt WW. The 1995 Ciba-Geigy Award Lecture. Intrinsic regulation of hepatic blood flow. Can J Physiol Pharmacol 1996; 74: 223–233
   PubMed Web of Science ®Google Scholar
• Wendon J. A., Harrison P. M., Keays R., Williams R. Cerebral blood flow and metabolism in fulminant liver failure. Hepatology 1994; 19: 1407–1413
   PubMed Web of Science ®Google Scholar
• Jaeschke H., Mitchell JR. Mitochondria and xanthine oxidase both generate reactive oxygen species in isolated perfused rat liver after hypoxic injury. Biochem Biophys Res Commun 1989; 160: 140–147
   PubMed Web of Science ®Google Scholar
• Aruoma O. I., Halliwell B., Hoey B. M., Butler J. The anti-oxidant action ofN-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radio Biol Med 1989; 6: 593–597
   PubMed Web of Science ®Google Scholar
• Gressier B., Cabanis A., Lebegue S. Comparison of in vitro effects of two thiol-containing drugs on human neutrophils hydrogen peroxide production. Methods Find Exp Clin Pharmacol 1993; 15: 101–105
   PubMed Web of Science ®Google Scholar
• Bruno M. K., Cohen S. D., Khairallah EA. Antidotal effectiveness ofN-acetylcysteine in reversing acet-aminophen-induced hepatotoxicity. Enhancement of the proteolysis of arylated proteins. Biochem Pharmacol 1988; 37: 4319–4325
   PubMed Web of Science ®Google Scholar
• Hershkovitz E., Shorer Z., Levitas A., Tal A. Status epilepticus following intravenousN-acetylcysteine therapy. Isr J Med Sci 1996; 32: 1102–1104
   PubMedGoogle Scholar
• Dawson A. H., Henry D. A., McEwen J. Adverse reactions toN-acetylcysteine during treatment for paracetamol poisoning. Med J Aust 1989; 150: 329–331
   PubMed Web of Science ®Google Scholar
• Death after N-acetylcysteine. Lancet 1984; 1: 1421
   Web of Science ®Google Scholar
• Mroz L. S., Benitez J. G., Krenzelok EP. Angioedema with oralN-acetylcysteine. Ann Emerg Med 1997; 30: 240–241
   PubMed Web of Science ®Google Scholar
• Flanagan R. J., Meredith TJ. Use of JV-acetylcysteine in clinical toxicology. Am J Med 1991; 91: 131S–139S
   PubMed Web of Science ®Google Scholar
• Bonfiglio M. F., Traeger S. M., Hulisz D. T., Martin BR. Anaphylactoid reaction to intravenous acetylcysteine associated with electrocardiographic abnormalities. Ann Pharmacother 1992; 26: 22–25
   PubMed Web of Science ®Google Scholar
• Bowden C. A., Krenzelok EP. Clinical applications of commonly used contemporary antidotes. A US perspective. Drug Saf 1997; 16: 9–47
   PubMed Web of Science ®Google Scholar
• Casey P. B., Tracey JA. N-acetylcysteine (NAC)—A safe antidote in paracetamol poisoning. Ir Med J 1997; 90: 38
   PubMedGoogle Scholar
• Jones A. L., Bangash J. H., Bouchier I. A., Hayes PC. Portal and systemic haemodynamic action ofN-acetylcysteine in patients with stable cirrhosis. Gut 1994; 35: 1290–1293
   PubMed Web of Science ®Google Scholar
• Jones A. L., Haynes W., MacGilchrist A. T., Webb D. J., Hayes PC. N-acetylcysteine acts as a potent peripheral vasodilator. Gut 1994; 35: S10, W40
   PubMedGoogle Scholar
• Overbeck H. W., Grega GJ. Response of the limb vascular bed in man to intrabrachial arterial infusions of hypertonic dextrose or hypertonic sodium chloride solutions. Grc Res 1970; 26: 717–731
   Google Scholar
• Chong S., Fung HL. Biochemical and pharmacological interactions between nitroglycerin and thiols. Effects of thiol structure on nitric oxide generation and tolerance reversal. Bichem Pharmacol 1991; 42: 1433–1439
   PubMed Web of Science ®Google Scholar
• Peake S. L., Moran J. L., Leppard PI. N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med 1996; 24: 1302–1310
   PubMed Web of Science ®Google Scholar